Treasury Secretary Steven Mnuchin is raising red flags ahead of Facebook's proposed cryptocurrency launch.Marketsread more
Some White House officials expect the Cabinet secretary, who has known the president for years, to depart as soon as this summer.Politicsread more
The Guggenheim CIO says he had been approached by the White House about possibly joining the Federal Reserve.The Fedread more
Epstein is accused of sexually exploiting dozens of underage girls from 2002 through 2005 at his New York and Florida residences. He is a former friend of Presidents Donald...Politicsread more
When you think of Prime Day, you might be thinking about deals on Instant Pots and Amazon Echo devices — not half-off dresses and designer heels. But the market for apparel...Retailread more
Joe Lonsdale says his fellow Palantir co-founder Peter Thiel was "courageous" for speaking out against Alphabet's Google.Technologyread more
Wall Street analysts say it is increasingly possible the Trump administration will try using a stronger weapon in the currency wars than just presidential tweets.Market Insiderread more
In his prepared testimony for Tuesday's Senate banking committee hearing, Facebook's David Marcus tells lawmakers that the Libra currency will be secure.Technologyread more
Twitter has rebuilt its website from the ground up for the first time ever, here's what it looks like.Technologyread more
Amazon is expanding its empire and Morgan Stanley believes Bezos' ambitious satellite internet plan could become very lucrative.Investing in Spaceread more
Crocs are becoming increasingly popular among teenagers because the shoes are ugly.Retailread more
Intermountain Healthcare made a splash in January when it said it and other major hospital systems, fed up with drug shortages and skyrocketing prices, planned to manufacture their own generic medicines.
Now it has a plan for how it's going to do it. The Salt Lake City-based hospital system is teaming with the Mayo Clinic, HCA Healthcare and four others to form a nonprofit company called Civica Rx. The seven organizations, the company said in a statement Thursday, represent about 500 U.S. hospitals.
The initial focus will be a group of 14 generic drugs that are administered to patients in the hospital. The consortium wouldn't name which they are, but said its first goal is to stabilize supply of essential generic medicines, and that it expects to have its first products on the market as early as next year. Civica Rx will be an Food and Drug Administration-approved manufacturer and will either directly make the drugs itself, or will contract the work out, the company said.
Civica also named a chief executive: Martin Van Trieste, former chief quality officer for biotech giant Amgen.
"We are creating a public asset with a mission to ensure that essential generic medications are accessible and affordable," Van Trieste said in the statement. "This will improve the situation for patients by bringing much needed competition to the generic drug market."
Though the generic drug system is designed to create low-cost versions of branded medicines, lack of competition and other factors have led to continued shortages of certain products, or skyrocketing prices.
Such was the case for Daraprim, the decades-old anti-parasitic drug acquired by Martin Shkreli, who raised the price by 5,000 percent overnight. Or a number of drugs acquired by Valeant Pharmaceuticals, which then boosted prices. The Cleveland Clinic said two heart drugs alone, acquired by Valeant, cost it more than $5 million a year. (Valeant is now know as Bausch Health.)
Without competition, hospitals were left without other options. Now they plan to create their own.
The four other organizations that will govern the nonprofit company are Catholic Health Initiatives, Providence St. Joseph Health, SSM Health and Trinity Health. The U.S. Department of Veterans Affairs, the company said, "will also work in consultation with Civica Rx to address its particular needs."
The Laura and John Arnold Foundation, which has focused on combating high drug prices and other health costs, along with the Peterson Center on Healthcare and the Gary and Mary West Foundation, also focused on affordable health care, will also govern the new company.